Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Citi
Farmers Insurance
Mallinckrodt
Novartis
Queensland Health
Moodys
Cipla
Boehringer Ingelheim

Generated: February 20, 2018

DrugPatentWatch Database Preview

Dexamethasone sodium phosphate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dexamethasone sodium phosphate and what is the scope of dexamethasone sodium phosphate patent protection?

Dexamethasone sodium phosphate
is the generic ingredient in thirteen branded drugs marketed by Ucb Inc, Merck, Cent Pharms, Abraxis Pharm, Fresenius Kabi Usa, Akorn, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Organon Usa Inc, Pharmafair, Alcon, Sola Barnes Hind, Bausch And Lomb, Sandoz Inc, and Alcon Pharms Ltd, and is included in forty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for dexamethasone sodium phosphate. Twenty-one suppliers are listed for this compound.
Pharmacology for dexamethasone sodium phosphate

US Patents and Regulatory Information for dexamethasone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate INJECTABLE;INJECTION 085606-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck NEODECADRON dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 050322-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm DEXAMETHASONE dexamethasone sodium phosphate INJECTABLE;INJECTION 088448-001 Jan 25, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bausch And Lomb NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 064055-001 Oct 30, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cent Pharms DEXACEN-4 dexamethasone sodium phosphate INJECTABLE;INJECTION 084342-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmafair DEXAIR dexamethasone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 088433-001 Dec 15, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dell Labs DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate INJECTABLE;INJECTION 083161-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alcon Pharms Ltd NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 062714-001 Jul 21, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmafair DEXAIR dexamethasone sodium phosphate OINTMENT;OPHTHALMIC 088071-001 Dec 28, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck DECADRON dexamethasone sodium phosphate INJECTABLE;INJECTION 012071-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Express Scripts
Harvard Business School
Chubb
Colorcon
Farmers Insurance
Cipla
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot